These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30986826)

  • 1. Scam Awareness Related to Incident Alzheimer Dementia and Mild Cognitive Impairment: A Prospective Cohort Study.
    Boyle PA; Yu L; Schneider JA; Wilson RS; Bennett DA
    Ann Intern Med; 2019 May; 170(10):702-709. PubMed ID: 30986826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scam Awareness Measure Related to Development of Alzheimer Dementia.
    Ann Intern Med; 2019 May; 170(10):. PubMed ID: 30986827
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons.
    Boyle PA; Buchman AS; Barnes LL; Bennett DA
    Arch Gen Psychiatry; 2010 Mar; 67(3):304-10. PubMed ID: 20194831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare and Financial Decision Making and Incident Adverse Cognitive Outcomes among Older Adults.
    Stewart CC; Yu L; Wilson RS; Bennett DA; Boyle PA
    J Am Geriatr Soc; 2019 Aug; 67(8):1590-1595. PubMed ID: 30882910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Stroke and Cerebrovascular Pathologies With Scam Susceptibility in Older Adults.
    Kapasi A; Schneider JA; Yu L; Lamar M; Bennett DA; Boyle PA
    JAMA Neurol; 2023 Jan; 80(1):49-57. PubMed ID: 36315115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia.
    Guo J; Wang J; Dove A; Chen H; Yuan C; Bennett DA; Xu W
    JAMA Psychiatry; 2022 Dec; 79(12):1180-1187. PubMed ID: 36287554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Amyloid-β Pathology with Decision Making and Scam Susceptibility.
    Kapasi A; Yu L; Stewart C; Schneider JA; Bennett DA; Boyle PA
    J Alzheimers Dis; 2021; 83(2):879-887. PubMed ID: 34366345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.
    Roberts RO; Aakre JA; Kremers WK; Vassilaki M; Knopman DS; Mielke MM; Alhurani R; Geda YE; Machulda MM; Coloma P; Schauble B; Lowe VJ; Jack CR; Petersen RC
    JAMA Neurol; 2018 Aug; 75(8):970-979. PubMed ID: 29710225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
    Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
    JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life space and risk of Alzheimer disease, mild cognitive impairment, and cognitive decline in old age.
    James BD; Boyle PA; Buchman AS; Barnes LL; Bennett DA
    Am J Geriatr Psychiatry; 2011 Nov; 19(11):961-9. PubMed ID: 21430509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative.
    Spencer BE; Jennings RG; Brewer JB;
    J Alzheimers Dis; 2019; 68(4):1549-1559. PubMed ID: 30958366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian disturbances in Alzheimer's disease progression: a prospective observational cohort study of community-based older adults.
    Li P; Gao L; Gaba A; Yu L; Cui L; Fan W; Lim ASP; Bennett DA; Buchman AS; Hu K
    Lancet Healthy Longev; 2020 Dec; 1(3):e96-e105. PubMed ID: 34179863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Aversion and Alzheimer Disease in Old Age.
    Wilson RS; Yu L; Schneider JA; Bennett DA; Boyle PA
    Am J Geriatr Psychiatry; 2019 Aug; 27(8):851-861. PubMed ID: 30982702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
    Jansen WJ; Ossenkoppele R; Tijms BM; Fagan AM; Hansson O; Klunk WE; van der Flier WM; Villemagne VL; Frisoni GB; Fleisher AS; Lleó A; Mintun MA; Wallin A; Engelborghs S; Na DL; Chételat G; Molinuevo JL; Landau SM; Mattsson N; Kornhuber J; Sabri O; Rowe CC; Parnetti L; Popp J; Fladby T; Jagust WJ; Aalten P; Lee DY; Vandenberghe R; Resende de Oliveira C; Kapaki E; Froelich L; Ivanoiu A; Gabryelewicz T; Verbeek MM; Sanchez-Juan P; Hildebrandt H; Camus V; Zboch M; Brooks DJ; Drzezga A; Rinne JO; Newberg A; de Mendonça A; Sarazin M; Rabinovici GD; Madsen K; Kramberger MG; Nordberg A; Mok V; Mroczko B; Wolk DA; Meyer PT; Tsolaki M; Scheltens P; Verhey FRJ; Visser PJ; ; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BNM; Blennow K; van Buchem MA; Cavedo E; Chen K; Chipi E; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gkatzima O; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Johannsen P; Klimkowicz-Mrowiec A; Köhler S; Koglin N; van Laere K; de Leon M; Lisetti V; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Nordlund A; Novak GP; Paraskevas GP; Perera G; Peters O; Ramakers IHGB; Rami L; Rodríguez-Rodríguez E; Roe CM; Rot U; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Zetterberg H
    JAMA Psychiatry; 2018 Jan; 75(1):84-95. PubMed ID: 29188296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.
    Rosenberg PB; Mielke MM; Appleby BS; Oh ES; Geda YE; Lyketsos CG
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):685-95. PubMed ID: 23567400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease frequency peaks in the tenth decade and is lower afterwards.
    Farfel JM; Yu L; Boyle PA; Leurgans S; Shah RC; Schneider JA; Bennett DA
    Acta Neuropathol Commun; 2019 Jul; 7(1):104. PubMed ID: 31269985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory Dysfunction and Incidence of Motoric Cognitive Risk Syndrome: A Prospective Clinical-Pathologic Study.
    Kravatz NL; Ayers E; Bennett DA; Verghese J
    Neurology; 2022 Oct; 99(17):e1886-e1896. PubMed ID: 36240083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.